Who owns the ALCANZA INCLUSIVE CLINICAL RESEARCH trademark?

The ALCANZA INCLUSIVE CLINICAL RESEARCH trademark is owned by Alcanza Clinical Research, LLC.

What class is the ALCANZA INCLUSIVE CLINICAL RESEARCH trademark registered in?

The ALCANZA INCLUSIVE CLINICAL RESEARCH trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ALCANZA INCLUSIVE CLINICAL RESEARCH?

The USPTO serial number for ALCANZA INCLUSIVE CLINICAL RESEARCH is 97353268.

What is the registration number for ALCANZA INCLUSIVE CLINICAL RESEARCH?

ALCANZA INCLUSIVE CLINICAL RESEARCH is registered under USPTO registration number 7311297.

ALC

USPTO Trademark Record

REGISTERED

ALCANZA INCLUSIVE CLINICAL RESEARCH

SN 97353268·Reg 7311297·Filed Apr 08, 2022

Owner Alcanza Clinical Research, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ALCANZA INCLUSIVE CLINICAL RESEARCH (Serial No. 97353268), Registration No. 7311297, is a registered US trademark filed on Apr 08, 2022 by Alcanza Clinical Research, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: February 20, 2030

Mark Intelligence

ALCANZA INCLUSIVE CLINICAL RESEARCH (Reg. #7311297) is a registered US trademark that has been protecting its owner, Alcanza Clinical Research, LLC, since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 08, 2022

SERIAL

97353268

REG#

7311297

REGISTERED

Feb 20, 2024

Owner

Applicant

Alcanza Clinical Research, LLC

Entity

LLC

State

Address

615 Crescent Executive Court, Suite 120, Lake Mary, FL, 32746

Country

Attorney

NameMark A. Wright

Law firm

Mark A. Wright MCLANE MIDDLETON, PROFESSIONAL ASSOCIATION

Docket

123175

Address

900 ELM STREET, P.O. BOX 326, MANCHESTER, NH 03105-0326, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 08, 2022

Serial Number97353268

Registration No.7311297

Registration DateFeb 20, 2024

Status DateFeb 20, 2024

Published for OppositionApr 11, 2023

Mark TypeStandard characters

Attorney Docket123175

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 30, 2023

First use in commerce: Nov 30, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

31 events

REGISTERED-PRINCIPAL REGISTER

Feb 20, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 20, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 29, 2024

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 29, 2024

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 29, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 29, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 29, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 17, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 16, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 20, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 19, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Dec 19, 2023

SOU EXTENSION 1 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Dec 19, 2023

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Nov 30, 2023

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Nov 30, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Nov 30, 2023

SOU EXTENSION 1 FILED

USE AMENDMENT FILED

Nov 30, 2023

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 06, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 11, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 11, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 22, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 08, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 07, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 07, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 07, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Jan 26, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jan 26, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 26, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 26, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Apr 12, 2022

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 12, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ALCANZA INCLUSIVE CLINICAL RESEARCH

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Alcanza Clinical Research, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Mark A. Wright

Resources

Company